Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sartorius AG (GB:0NIR)
LSE:0NIR
Sartorius (0NIR) Share Price & Analysis
6 Followers
0NIR Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€200.30 - €383.50
Previous Close€222.57
Volume38.53K
Average Volume (3M)20.84K
Market Cap
€13.00B
Enterprise Value€16.01B
Total Cash (Recent Filing)€196.80M
Total Debt (Recent Filing)€2.54B
Price to Earnings (P/E)196.8
Beta1.73
Next Earnings
Oct 17, 2024EPS Estimate
€1.06Last Dividend Ex-Date
Apr 02, 2024Dividend Yield0.36%
Share Statistics
EPS (TTM)1.13
Shares Outstanding37,440,000
10 Day Avg. Volume9,437
30 Day Avg. Volume20,840
Standard Deviation0.13
R-Squared0.00266
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€274.92Price Target Upside23.52% Upside
Rating ConsensusHold
Number of Analyst Covering13
Sartorius News
PremiumPre-Earnings
Is 0NIR a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Cost ManagementAnnounced cost cuts of €100m in 2024 and €130m in 2025 highlight strong efforts in cost control.
Financial PerformanceSartorius reported financial income of EUR 34m, significantly exceeding the previous estimate of EUR 20.4m.
Growth OutlookSigns of improvement in end markets, solid cost control, and easing comparisons are reasons for optimism.
Bears Say
DebtNet income reflects significantly higher interest expenses as debt soared to EUR 5.3bn at the end of FY 2023 as a result of the Polyplus acquisition.
Financial PerformanceSales and margins down following last night's profit warning.
Order IntakeSartorius released Q2 24 figures in line with expectations, but lowered its FY 2024 guidance due to lacklustre order intake.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
17.38% Mutual Funds
10.65% Other Institutional Investors
71.96% Public Companies and
Individual Investors
0NIR FAQ
What was Sartorius AG’s price range in the past 12 months?
Sartorius AG lowest share price was €200.30 and its highest was €383.50 in the past 12 months.
What is Sartorius AG’s market cap?
Currently, no data Available
When is Sartorius AG’s upcoming earnings report date?
Sartorius AG’s upcoming earnings report date is Oct 17, 2024 which is in 84 days.
How were Sartorius AG’s earnings last quarter?
Sartorius AG released its earnings results on Jul 18, 2024. The company reported €0.34 earnings per share for the quarter, missing the consensus estimate of €0.976 by -€0.636.
Is Sartorius AG overvalued?
According to Wall Street analysts Sartorius AG’s price is currently Undervalued.
Does Sartorius AG pay dividends?
Sartorius AG pays a Annually dividend of €0.74 which represents an annual dividend yield of 0.36%. See more information on Sartorius AG dividends here
What is Sartorius AG’s EPS estimate?
Sartorius AG’s EPS estimate is €1.06.
How many shares outstanding does Sartorius AG have?
Sartorius AG has 37,440,000 shares outstanding.
What happened to Sartorius AG’s price movement after its last earnings report?
Sartorius AG reported an EPS of €0.34 in its last earnings report, missing expectations of €0.976. Following the earnings report the stock price went up 1.359%.
Which hedge fund is a major shareholder of Sartorius AG?
Currently, no hedge funds are holding shares in GB:0NIR
---
Sartorius Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€274.92 (23.52% Upside)
€274.92 (23.52% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.24%
12-Months-Change
Fundamentals
Return on Equity
3.27%
Trailing 12-Months
Asset Growth
41.18%
Trailing 12-Months
Company Description
Sartorius AG
Sartorius AG is the leading provider of biopharmaceutical fermentation and fluid management. In 2019, the bioprocess division contributed 77% to total revenue and the lab division the remaining 23%. The bioprocess division is traded as a separate company, Sartorius Stedim Biotech. Sartorius AG has a 74% ownership of this subsidiary with 85% voting control. In addition to biomanufacturing equipment and consumables, Sartorius offers a wide range of products for general lab use, such as scales, pipettes, and filtration equipment. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (38% of 2019 sales), the Americas (37%), and Asia-Pacific (25%). Sartorius employs over 9,000 people and has operations in more than 30 countries.
---
0NIR Stock 12 Month Forecast
Average Price Target
€274.92
▲(23.52% Upside)
Technical Analysis
Best Analysts Covering 0NIR
1 Year
1 Year Success Rate
11/34 ratings generated profit
1 Year Average Return
+2.49%
reiterated a buy rating 7 days ago
Copying Richard Vosser's trades and holding each position for 1 Year would result in 32.35% of your transactions generating a profit, with an average return of +2.49% per trade.
---